Scarica l'app Stockscreener
0.56
41.03%
-0.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BCLI Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.17
Aprire:
$0.56
Volume 24 ore:
13,217
Relative Volume:
66.00
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
$-16.63M
Rapporto P/E:
-1.3023
EPS:
-0.43
Flusso di cassa netto:
$-21.84M
1 W Prestazione:
-41.03%
1M Prestazione:
-43.90%
6M Prestazione:
-68.49%
1 anno Prestazione:
-87.10%
Intervallo 1D:
$0.56
$0.59
Intervallo di 1 settimana:
$0.56
$0.59
Portata 52W:
$0.56
$0.59
Brainstorm Cell Therapeutics Inc Stock (BCLI) Company Profile
Nome
Brainstorm Cell Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BCLI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCLI
Brainstorm Cell Therapeutics Inc
|
0.56 | 0 | 0 | -16.63M | -21.84M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-04 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-11-17 | Downgrade | Maxim Group | Buy → Hold |
| 2016-12-19 | Reiterato | Maxim Group | Buy |
| 2015-12-22 | Reiterato | Maxim Group | Buy |
Brainstorm Cell Therapeutics Inc Borsa (BCLI) Ultime notizie
Is Brainstorm Cell Therapeutics Inc GHD a good long term investmentMarket Sentiment Extremes & Small Entry Cost Investments - earlytimes.in
Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight - The Malaysian Reserve
Why analysts raise outlook for Brainstorm Cell Therapeutics Inc. (GHD) stockTrade Exit Summary & Low Risk High Win Rate Picks - Newser
Can Brainstorm Cell Therapeutics Inc. (GHD) stock sustain double digit ROEWeekly Trend Report & Fast Gain Stock Tips - Newser
Will Brainstorm Cell Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Sentiment & Safe Entry Point Alerts - Newser
How Brainstorm Cell Therapeutics Inc. (GHD) stock trades in high volatilityWeekly Investment Recap & Community Supported Trade Ideas - Newser
Why analysts recommend Brainstorm Cell Therapeutics Inc. (GHD) stockWeekly Gains Summary & Weekly Breakout Stock Alerts - Newser
How supply chain issues affect Brainstorm Cell Therapeutics Inc. stock2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser
What hedge fund moves indicate for Brainstorm Cell Therapeutics Inc. (GHD) stockPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
How Brainstorm Cell Therapeutics Inc. (GHD) stock valuation compares with sector2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - Aktiellt
BCLI Interactive Stock Chart | BrainStorm Cell Therapeutics In Stock - Yahoo Finance
FDA Review of Citizen Petition Offers a Fresh Look at NurOwn®'s Evidence of Treatment Effectiveness (PR Newswire) - Aktiellt
Will Brainstorm Cell Therapeutics Inc. (GHD) stock outperform energy sector in 2025Weekly Profit Report & Accurate Buy Signal Notifications - newser.com
How higher bond yields impact Brainstorm Cell Therapeutics Inc. (GHD) stockTrade Entry Summary & Safe Entry Point Identification - newser.com
Will Brainstorm Cell Therapeutics Inc. (GHD) stock see valuation expansion2025 Trading Recap & Growth Oriented Trade Recommendations - newser.com
Can Brainstorm Cell Therapeutics Inc. stock hit record highs againWeekly Market Summary & Real-Time Market Sentiment Reports - newser.com
Why Brainstorm Cell Therapeutics Inc. stock remains on watchlistsJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Long term hold vs stop loss in Brainstorm Cell Therapeutics Inc.Quarterly Profit Report & AI Driven Price Forecasts - newser.com
Real time social sentiment graph for Brainstorm Cell Therapeutics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
What momentum indicators show for Brainstorm Cell Therapeutics Inc. stockNew Guidance & Daily Price Action Insights - newser.com
Can a trend reversal in Brainstorm Cell Therapeutics Inc. lead to recoveryGlobal Markets & Weekly Stock Breakout Alerts - newser.com
Analyzing Brainstorm Cell Therapeutics Inc. with risk reward ratio chartsJuly 2025 Momentum & Daily Chart Pattern Signals - newser.com
Published on: 2025-11-16 07:51:55 - newser.com
Understanding Brainstorm Cell Therapeutics Inc.’s price movementMarket Volume Report & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-11-16 01:49:47 - newser.com
Published on: 2025-11-15 18:37:45 - newser.com
Brainstorm Cell Therapeutics Inc Azioni (BCLI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Capitalizzazione:
|
Volume (24 ore):